A
Agilent Technologies, Inc.
Diagnostics & Research · Healthcare · United States
181.15
close · 2026-10-29
value
52
cheaper than peers52
quality
73
stronger fundamentals73
ranked against
Diagnostics & Research
value
quality
31 peers
Value inputs
| measure | company | vs peers |
| forward P/E | 26.92× | 63 |
| EV to EBITDA | 21.67× | 62 |
| price to sales | 5.73× | 44 |
| price to book | 6.94× | 43 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 23.6% | 92 |
| return on equity | 21.0% | 78 |
| debt to equity | 53.6% | 50 |
| revenue growth | 8.1% | 31 |
4 of 4 measures available
Facts
| market cap | $51B |
| free cash flow | $1.07B |
| employees | 18,000 |
| first trade | 1999-11-18 |
| next earnings | 2026-11-23 |
| fundamentals updated | 2026-09-01 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 4.57 | 4.43 | 4.19 | 4.18 |
| free cash flow | $1.15B | $1.37B | $1.47B | $1.02B |
| net income | $1.30B | $1.29B | $1.24B | $1.25B |
| revenue | $6.95B | $6.51B | $6.83B | $6.85B |